Sterling Financial Planning, Inc. Charles River Laboratories International, Inc. Transaction History

Sterling Financial Planning, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$204.13 - $302.4 $152,076 - $225,287	-745 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$351.38 - $448.68 $15,812 - $20,190	45 Added 6.43%	745 $281,000
Q3 2021 Oct 28, 2021	BUY	$372.64 - $458.3 $111,792 - $137,490	300 Added 75.0%	700 $289,000
Q2 2021 Aug 02, 2021	BUY	$294.17 - $371.65 $117,668 - $148,660	400 New	400 $148,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Sterling Financial Planning, Inc., based on Form 13F filings with the SEC.

Stay updated on Sterling Financial Planning, Inc. with notifications on news.